Healthcare M&A » By The Online Investor Staff, updated Tue., Jan. 26, 2:53 AM
Recent mergers and acquisitions in the Healthcare M&A category.
Slide #80. Intrexon Corporation — Medistem
| Acquirer: |
Intrexon Corporation (XON) |
| Acquiree: |
Medistem (MEDS) |
| Details: |
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it has completed the acquisition of San Diego-based Medistem, Inc. (OTCQB: MEDS), a pioneer in the development of Endometrial Regenerative Cells ("ERC" or "ERCs"), universal donor adult-derived stem cells with properties uniquely suited for therapeutic use with Intrexon's existing suite of synthetic biology technologies. Upon integration of these platforms, ERCs could be manufactured as genetically modified vehicles to secrete powerful therapeutic effectors in the body for clinical benefit to patients suffering from many different diseases. |
Intrexon is engaged in the field of synthetic biology, focusing on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. Using its suite of technologies, Co. designs, builds and regulates gene programs, which are DNA sequences that consist of primary genetic components. A single gene program or a complex, multi-genic program is fabricated and stored within a DNA vector. Vectors are segments of DNA used as a vehicle to transmit genetic information. Co.'s primary domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Hungary.
Open the XON Page at The Online Investor »
Intrexon is engaged in the field of synthetic biology, focusing on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. Using its suite of technologies, Co. designs, builds and regulates gene programs, which are DNA sequences that consist of primary genetic components. A single gene program or a complex, multi-genic program is fabricated and stored within a DNA vector. Vectors are segments of DNA used as a vehicle to transmit genetic information. Co.'s primary domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Hungary.
Open the MEDS Page at The Online Investor »
| Company Name: |
| Trxade Group, Inc. |
| Sector: |
| Application Software |
| Number of ETFs Holding MEDS: |
| 1 |
| Total Market Value Held by ETFs: |
| $50641 |
| Total Market Capitalization: |
| $49.00M |
| % of Market Cap. Held by ETFs: |
| 0.10% |
|
Quotes delayed 20 minutes
|
